When.com Web Search

  1. Ads

    related to: ketamine nasal spray dosing

Search results

  1. Results From The WOW.Com Content Network
  2. Esketamine - Wikipedia

    en.wikipedia.org/wiki/Esketamine

    Esketamine, sold under the brand names Spravato (for depression) and Ketanest (for anesthesia) among others, [10] [12] is the S(+) enantiomer of ketamine. [5] [13] It is a dissociative hallucinogen drug used as a general anesthetic and as an antidepressant for treatment of depression.

  3. Ketamine-assisted psychotherapy - Wikipedia

    en.wikipedia.org/wiki/Ketamine-assisted...

    Since 2010, ketamine has been prescribed off-label to patients with severe depression with the informed consent of patients. [26] In 2019, the FDA approved the use of esketamine (Spravato) as a nasal spray, in conjunction with an oral antidepressant, for treatment-resistant depression in adults.

  4. The U.S. Food and Drug Administration expanded approval for Johnson & Johnson’s nasal spray, ... The ketamine-derived drug was first approved in 2019 to be used in combination with ...

  5. Ketamine - Wikipedia

    en.wikipedia.org/wiki/Ketamine

    Ketamine potentiates the sedative effects of propofol [86] and midazolam. [87] Naltrexone potentiates psychotomimetic effects of a low dose of ketamine, [88] while lamotrigine [38] and nimodipine [39] decrease them. Clonidine reduces the increase of salivation, heart rate, and blood pressure during ketamine anesthesia and decreases the ...

  6. Nasal esketamine works better than alternative for treatment ...

    www.aol.com/news/nasal-esketamine-works-better...

    A nasal spray version of esketamine was more effective for depression that is resistant to treatment than a more commonly used drug, research published Wednesday in The New England Journal of ...

  7. FDA approves Johnson & Johnson’s ketamine-derived nasal spray ...

    www.aol.com/finance/fda-approves-johnson-johnson...

    The nasal spray was first approved by the FDA in 2019 as a supplemental treatment, along with an oral medication, for the approximately one-third of people with MDD who struggle with treatment ...